Literature DB >> 7798930

Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family.

J E Lachowicz1, Y Shen, F J Monsma, D R Sibley.   

Abstract

A cDNA clone encoding a novel G protein-linked receptor was isolated from a rat cerebral cortex cDNA library using a polymerase chain reaction-amplified cDNA fragment as a probe. This 2.4-kb clone encodes a 367 amino acid protein with seven putative transmembrane spanning domains. The protein is highly homologous to the cloned micro, delta, and kappa opioid receptors and shares with them structural features such as three glycosylation sites in the amino terminus, a cyclic AMP-dependent kinase phosphorylation site in the third cytoplasmic loop, an aspartic acid residue in the second transmembrane domain, and a palmitoylation site on the intracellular carboxy terminus. The receptor is also homologous with members of the somatostatin receptor family, yet it binds neither opiate nor somatostatin ligands. Northern blot analysis reveals two transcripts of 3.2 and 7.6 kb that are predominantly expressed in the cerebral cortex and hypothalamus. In situ hybridization analysis also shows a high abundance of mRNA in the cerebral cortex, hippocampus, amygdala, hypothalamus, thalamus, and dorsal raphe nuclei. It is suggested that the endogenous ligand for this receptor may represent a novel neuropeptide that may be closely related to the opiate peptide family.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7798930     DOI: 10.1046/j.1471-4159.1995.64010034.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  36 in total

1.  Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.

Authors:  M Narita; H Mizoguchi; D E Oji; N J Dun; B H Hwang; H Nagase; L F Tseng
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 2.  Visualizing activation of opioid circuits by internalization of G protein-coupled receptors.

Authors:  Kevin Sinchak; Paul Micevych
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

3.  Orphanin FQ/nociceptin interacts with the basolateral amygdala noradrenergic system in memory consolidation.

Authors:  Benno Roozendaal; Ray Lengvilas; James L McGaugh; Olivier Civelli; Rainer K Reinscheid
Journal:  Learn Mem       Date:  2007-01-03       Impact factor: 2.460

4.  Release of orphanin FQ/nociceptin in the medial preoptic nucleus and ventromedial nucleus of the hypothalamus facilitates lordosis.

Authors:  Kevin Sinchak; Phoebe Dewing; Misty Cook; Paul Micevych
Journal:  Horm Behav       Date:  2006-12-22       Impact factor: 3.587

5.  Nociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in mice.

Authors:  G C Sartor; S K Powell; H J Wiedner; C Wahlestedt; S P Brothers
Journal:  Brain Res       Date:  2015-12-03       Impact factor: 3.252

6.  Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.

Authors:  T Sakurada; S Katsuyama; S Sakurada; M Inoue; K Tan-No; K Kisara; C Sakurada; H Ueda; J Sasaki
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 7.  Orphan anxiety.

Authors:  J R Walker; G F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 8.  Extranuclear signaling by ovarian steroids in the regulation of sexual receptivity.

Authors:  Paul E Micevych; Kevin Sinchak
Journal:  Horm Behav       Date:  2018-05-18       Impact factor: 3.587

Review 9.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

Review 10.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.